Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors.

@article{Vitale2011InitialEW,
  title={Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors.},
  author={Felice Vito Vitale and Placido Romeo and Enrico Maria Di Maggio and Alessandra Parisi and Emilia Malaponte and Stefania Cal{\`i} and Fabio Vasta and Vincenzo Panebianco and Domenico Arcoria and Francesco Ferra{\`u}},
  journal={Anticancer research},
  year={2011},
  volume={31 12},
  pages={4553-9}
}
BACKGROUND Locoregional treatments represent a good option for patients suffering from hepatocellular carcinoma (HCC) not eligible for resection or transplantation. Locoregional approaches include a wide spectrum of therapeutic methods and hepatic intra-arterial drug infusion is also considered. Fotemustine is a chemotherapy drug usually administered… CONTINUE READING